Login Privacy Policy Legal Statement Sitemap Contact Us Search Registration

Home/EN/Services/Sitemap Sitemap  About cancer About Cancer Screening Treatment Surgery Chemotherapy Radiation therapy Biological therapy Coping with cancer Coping with cancer Fatigue Fatigue Causes Assessment Pain Pain Assessment Management with Drugs Physical and Psychosocial Interventions Anticancer Interventions What is angiogenesis? What is angiogenesis? About angiogenesis About VEGF About anti-VEGF Breast cancer Breast cancer Prevention Diagnosis Treatment Colorectal cancer Colon and rectal cancer Prevention Diagnosis Treatment Lung cancer Non small cell lung cancer Prevention Diagnosis Treatment Renal cell cancer Renal cell cancer Prevention Diagnosis Treatment Clinical cases Case N°2 Case N°3 Case N°4 Case N°5 Expert reviews Review: Bevacizumab for lung cancer Review: Bevacizumab in the Treatment of Metastatic Breast Cancer Review: Bevacizumab for the treatment of metastatic renal cancer Review: Bevacizumab in the treatment of glioblastoma multiforme Review: Trastuzumab for the treatment of advanced gastric cancer Review: Erlotinib for the treatment of lung cancer Review: Trastuzumab for the treatment of metastatic breast cancer Review: Rituximab for the treatment of lymphomas Highlights Safety of Bevacizumab in Patients with Brain Metatastases: Results from the PASSPORT study Sequential therapy offers new perspectives to patients with renal cancer Trastuzumab plus Anastrozole: Results of the TAnDEM study Bevacizumab and Irinotecan Combination in the Treatment for Recurrent High-grade Gliomas Neoadjuvant chemotherapy with trastuzumab and anthracyclines Product information Avastin® About Avastin Avastin® development Efficacy Administration Angiogenesis Anti-VEGF Anti-VEGF VEGF Breast cancer Efficacy of Avastin® E2100 AVADO Trial Colorectal cancer E3200 Lung cancer Efficacy of Avastin® E4599 Trial AVAIL Trial Renal cell cancer Herceptin® Breast cancer HER 2+ Importance of HER2 testing in breast cancer IHC Diagnosis About Herceptin® Herceptin® development Administration Efficacy Adjunvant efficacy HERA Trial NCCTG N9831 Trial NSABP B-31 Trial BCIRG 006 Trial Neoadjuvant efficacy Metastasic breast cancer efficacy First line H0648g (pivotal trial) M77001 Trial Subsequent lines of therapy Hormone receptor co-positive tumours Safety Cardiac safety Dosage Dosage and administration in early breast cancer Dosage and administration in metastatic breast cancer Mabthera® About Mabthera® Mabthera® development Safety Administration Tarceva® About Tarceva® Tarceva® development Administration Xeloda® About Xeloda® Efficacy Breast cancer treatment efficacy Colon cancer adjuvant treatment efficacy Metastasic colorectal cancer treatment efficacy Safety Administration News News Webcasts ESMO 2010 ASCO 2010 ECCO/ESMO 2009 Latin American Avastin Forum of Excellence. Lima, 2009 Anti-angiogenesis Clinical Experience Exchange Meeting 2009 Services Login Login Privacy Policy Legal Statement Sitemap Contact Us Search Registration

Privacy Policy | Legal Statement The information on this Web site is intended only for visitors from Aruba, Bahamas, Barbados, Bermuda, Curacao, Jamaica, St. Maarten, St. Lucia and Trinidad & Tobago All rights reserved © 2008 F. Hoffmann-La Roche Ltd.